K Number
K241005
Date Cleared
2025-01-02

(265 days)

Product Code
Regulation Number
876.4400
Panel
GU
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The The Haemostasis Clips are indicated for endoscopic clip placement within the gastrointestinal tract for the purpose of:

  1. Endoscopic marking.
  2. Hemostasis for:
    Mucosal/sub-mucosal defects
Device Description

The Haemostasis Clips are sterile devices consisting of a pre-loaded, radiopaque, single-use, endoscopic clipping device consisting of two main components: the delivery system and the clip part. The delivery system consists of a handle assembly and delivery catheter assembly. The delivery system is constructed using stainless steel and polyester materials. The delivery system will allow for the device to rotate at the distal end. The delivery system is offered in 1650mm, 1950mm and 2350mm working lengths. The clip part consists of a stainless steel tightening capsule, movable pin and clip arms. The clip is deployed from the delivery system during use. The hemoclip jaws are engineered such that they can be opened and closed up to five times prior to deployment, aiding in repositioning of the clip at the lesion site. Re-opening, closing, and rotation capability may be limited by clinical circumstances and patient anatomy. There are no associated accessories included with this device.

AI/ML Overview

The provided text describes the 510(k) premarket notification for the "Haemostasis Clips" device. It outlines non-clinical testing performed to demonstrate substantial equivalence to a predicate device, rather than a study proving the device meets specific acceptance criteria based on clinical outcomes or a multi-reader, multi-case study in the traditional sense of AI/software device evaluation.

The device is a medical instrument (Haemostasis Clips), not a software device or AI system, so many of the requested categories for AI/software evaluation (like MRMC studies, training set details, or ground truth establishment by experts for performance metrics) are not applicable. The evaluations are focused on the physical and performance characteristics of the clips themselves.

Here's a breakdown of the information that can be extracted and which requested points are not applicable in this context:

1. A table of acceptance criteria and the reported device performance

The document doesn't explicitly list numerical acceptance criteria for each test. Instead, it states that the tests were performed and the results "Pass" or "meet the requirement". For biocompatibility, specific outcomes like "Non-cytotoxic" are listed.

TestReported Device Performance
AppearancePass
SizePass
Open and ClosePass
Rotation propertyPass
Separation and clamping propertiesPass
Clip release force testingPass
Clip hardnessPass
CorrosionPass
Connection strength before clip releasedPass
Breaking force of the delivery partPass
Clamping force maintenancePass
Chemical propertiesPass
In vitro cytotoxicityNon-cytotoxic
Skin sensitizationNon-sensitive
Intracutaneous reactivityNon-irritation
Acute systemic toxicityNon-acute systemic toxicity
PyrogenNon-pyrogenic
Hemolysis testNon Hemolysis reaction
Sub chronic toxicityNon-Sub chronic toxicity
Implantation effectNon-Implantation effect
Sterility Assurance Level (SAL)10⁻⁶ demonstrated
EO residualsMeets requirements
Shelf-life3 years (based on accelerated aging)

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document does not specify the sample sizes for each of the bench or biocompatibility tests. It also does not mention data provenance as these are non-clinical (laboratory/bench) tests on manufactured devices, not data-driven studies from human subjects.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not applicable. These are non-clinical, bench and biocompatibility tests for a physical medical device. "Ground truth" in the context of expert consensus on medical images or clinical outcomes is not relevant here. The "ground truth" for these tests are objective, measurable physical and chemical properties and biological reactions determined by standardized test methods.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable. This concept relates to human expert review and consensus, which is not part of the non-clinical bench or biocompatibility testing described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. The device is a physical medical instrument (Haemostasis Clip), not an AI/software device. Therefore, no MRMC study or evaluation of human reader improvement with AI assistance was performed or is relevant.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. The device is a physical medical instrument, not an algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

Not applicable. The "ground truth" for these tests are the inherent physical, chemical, and biological properties measured against established standards (e.g., ISO standards, "Pass" criteria for physical performance).

8. The sample size for the training set

Not applicable. This information pertains to machine learning models, which are not relevant to this device.

9. How the ground truth for the training set was established

Not applicable. This information pertains to machine learning models, which are not relevant to this device.

§ 876.4400 Hemorrhoidal ligator.

(a)
Identification. A hemorrhoidal ligator is a device used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or band placed around the hemorrhoid.(b)
Classification. Class II (special controls). Except for a hemostatic metal clip intended for use in the gastrointestinal tract, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.